求助文献全篇下载

baby00000003

Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement
* y( e, t- w; v, r( uM. Ueda, Y. Yamada, R. Ozawa, Y. Okazaki
* v+ v1 E! a3 `* Z8 M9 FDOI: http://dx.doi.org/10.1016/j.prosdent.2005.05.019
8 w: b/ [' n8 @0 S4 F2 V8 i9 w$ k8 z; x' b' s& F' I+ H* E8 w
感谢各位老师的无私援助～

farui

Noteworthy Abstracts of the Current Literature
- x6 n2 Y* j# _Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement
, C  n* Q% H. U0 W" I( j) |; X& T0 |3 Q" B& ?
    M. Ueda, Y. Yamada, R. Ozawa, Y. Okazaki- a1 G6 j- ^! t, y3 ^6 ~8 M
2 K+ F/ S/ c# s( _/ ?
Show more1 b5 L% c3 M' G% I- Q# l, Q

% b9 d! o# {, O$ {: c. P1 D$ T, N        doi:10.1016/j.prosdent.2005.05.019
/ Z4 q. n$ {0 O5 b( M- ?0 H    Get rights and content( f9 ^0 w, t( f# z! w

4 l0 j7 `6 E$ n7 Z& QThis clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height. All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success.—Reprinted with permission of Quintessence Publishing.
. l  @/ R3 F  B  N3 k7 O4 ^( R: _' T" K- u
整个PDF就这一点内容

baby00000003

回复 farui 的帖子' Z+ h4 P# r7 B8 w: t
7 d$ n3 u* V# i- e: ^1 @
那必然不是呀～